Stock comparison
Novartis AG is 589.8x more valuable than Evotec SE by market capitalization ($294.66 B vs $499.56 M). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NVS is larger
Novartis AG is 589.8x more valuable than Evotec SE by market capitalization ($294.66 B vs $499.56 M).
Market value leader
NVS
Novartis AG is 589.8x more valuable than Evotec SE by market capitalization ($294.66 B vs $499.56 M).
| Metric | EVO | NVS |
|---|---|---|
| Market cap | $499.56 M | $294.66 B |
| US-listed rank | #2671 | #46 |
| Net margin | - | - |
| P/E (trailing FY) | - | - |
| SEC filings | 180 | 981 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Novartis AG is 589.8x more valuable than Evotec SE by market capitalization ($294.66 B vs $499.56 M).
Full pages: Evotec SE and Novartis AG, or browse the full rankings.